Belimumab

Definition: Belimumab, sold under the brand name Benlysta, is a human monoclonal antibody that inhibits B-cell activating factor (BAFF), also known as B-lymphocyte stimulator (BLyS). It is approved in the United States and Canada, and the European Union to treat systemic lupus erythematosus and lupus nephritis. source: Wikipedia

ID

449043000

ID date

13 Oct 2011

Previous ID

18530511000001109

Name

Belimumab